Skip to main content

Table 2 Differentially expressed urine proteins

From: Plasma and urine biomarkers in acute viral hepatitis E

Identifier Protein Name Accession Number Fold Change Expt 1(HEV Cy5; CON Cy3) Fold Change Expt 2 (HEV Cy3; CON Cy5)
U1 Prostaglandin D2 synthase
21 kDa (Brain)
Q5SQ09 +2.16 -1.43
U2 - Zinc alpha 2 glycoprotein chain A
- Alpha 1 type I collagen, preprotein
1ZAGA
Q8N473_HUM
+4.97 -3.14
U3 Zinc alpha 2 glycoprotein chain A 1ZAGA +6.58 -3.74
U4 Zinc alpha 2 glycoprotein chain A 1ZAGA +6.98 -2.94
U5 KIAA0216 splice variant 1 Q5W9G1_HUM +4.40 -1.85
U6 - Membrane associated guanylate kinase 2
- ODF2 protein
AAC05370
Q5BJF6_HUM
+3.33 -1.75
U7 FLJ00133 fragment Q8TERO_HUM +9.08 -1.83
U8 Serum albumin AAA64922 -4.06 +8.67
U9 Serum albumin AAA64922 -2.52 +6.67
U10 N2B-Titin Isoform
RasGAP-activating-like protein 1 variant
CAD12455 +9.42 -3.81
U11 Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor HCHU +6.01 -3.63
U12 Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor HCHU +7.59 -4.21
U13 Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor HCHU +6.22 -2.81
  1. The differentially expressed urine proteins from Figure 3 were analysed by DeCyder 2D v6.5 and identified by mass spectrometry. The table shows the spot intensity fold-changes in hepatitis E patients (HEV) compared to healthy controls (CON). A dye swap experiment is also shown. The "+" and "-" values indicate increased or decreased expression, respectively, in patients compared to controls.